| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/27/1997 | DE19530868A1 Kapseln, enthaltend gefriergetrocknete, gepulverte grüne Teeblätter Capsules containing freeze-dried, powdered green tea leaves |
| 02/27/1997 | DE19530865A1 Wirkstoff sowie Mittel zur parenteralen Ernährung Drug and means for parenteral nutrition |
| 02/27/1997 | DE19530708A1 Pharmazeutisches Präparat mit trypanoziden Eigenschaften The pharmaceutical preparation with trypanocidal properties |
| 02/27/1997 | CA2235677A1 Prolylendopeptidase inhibitors |
| 02/27/1997 | CA2230195A1 A method to increase the density of antigen on antigen presenting cells |
| 02/27/1997 | CA2229938A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression |
| 02/27/1997 | CA2229797A1 Novel opioid peptides |
| 02/27/1997 | CA2229662A1 Endometrial ablation using photodynamic therapy with green porphyrins |
| 02/27/1997 | CA2229658A1 Combination osmotic and bulk forming laxatives |
| 02/27/1997 | CA2229554A1 Non-steroidal sulfatase inhibitor compounds and their method of use |
| 02/27/1997 | CA2229460A1 Radiation-activated cytotoxin therapy |
| 02/27/1997 | CA2229450A1 Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions |
| 02/27/1997 | CA2229287A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 02/27/1997 | CA2229269A1 Enediyne compounds |
| 02/27/1997 | CA2229264A1 Cyclopropylindoles and their seco precursors, and their use as prodrugs |
| 02/27/1997 | CA2229135A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/27/1997 | CA2229060A1 Method and composition for treating asthma |
| 02/27/1997 | CA2228965A1 Control of cd44 gene expression for therapeutic use |
| 02/27/1997 | CA2228765A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
| 02/27/1997 | CA2228521A1 Protection against pathogenic microorganisms |
| 02/27/1997 | CA2228036A1 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 02/27/1997 | CA2227795A1 Allergen-xcd32 fusion proteins |
| 02/27/1997 | CA2227585A1 Novel fused isoquinolines as dopamine receptor ligands |
| 02/27/1997 | CA2227384A1 Thienopyrimidine derivatives, their production and use |
| 02/27/1997 | CA2227174A1 Traf inhibitors |
| 02/27/1997 | CA2226735A1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 02/27/1997 | CA2226299A1 Hyper comb-branched polymer conjugates |
| 02/27/1997 | CA2223814A1 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents |
| 02/27/1997 | CA2203428A1 2-acylaminopropanamides as growth hormone secretagogues |
| 02/27/1997 | CA2203424A1 2-acylaminopropanamines as growth hormone secretagogues |
| 02/27/1997 | CA2202928A1 Poly(organo)phosphazenes for use in synthetic transfection systems |
| 02/26/1997 | EP0759466A2 Low binding affinity interleukin-12 beta receptors |
| 02/26/1997 | EP0759437A1 Processes for the production of 2-isocephem derivatives |
| 02/26/1997 | EP0759434A1 Benzothiophene compounds |
| 02/26/1997 | EP0759432A1 Use of medicaments containing 3,4-diaryl furans and analogs thereof for treating a skin-related condition |
| 02/26/1997 | EP0759301A2 Prevention and treatment of topical viral infections with perfluoropolyethers or compositions thereof |
| 02/26/1997 | EP0759300A1 Molten granulated sucralfate preparation and process for producing the same |
| 02/26/1997 | EP0759299A1 Potentiation of serotonin response |
| 02/26/1997 | EP0759298A2 Pyrazolopyrimidine derivates as antihypertensive agents |
| 02/26/1997 | EP0759297A1 Remedy for pulmonary heart |
| 02/26/1997 | EP0759296A1 Rapidly disintegrating formulation comprising tramadol or a tramadol salt |
| 02/26/1997 | EP0759295A1 Use of adamantan derivatives for the treatment of internal ear diseases |
| 02/26/1997 | EP0759294A2 Hypercholesterolemia therapeutic agent |
| 02/26/1997 | EP0759087A1 Compositions and methods for targeting gene delivery vehicles |
| 02/26/1997 | EP0759082A1 Dna construct for effecting homologous recombination and uses thereof |
| 02/26/1997 | EP0759067A1 Transforming growth factor alpha h1 |
| 02/26/1997 | EP0759027A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 02/26/1997 | EP0759026A1 Amide derivatives and their therapeutic use |
| 02/26/1997 | EP0759025A1 Amide derivatives and their therapeutic use |
| 02/26/1997 | EP0758897A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 02/26/1997 | EP0758896A1 Topical preparation containing aciclovir |
| 02/26/1997 | EP0758895A1 Dosage forms and method for ameliorating male erectile dysfunction |
| 02/26/1997 | EP0758894A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
| 02/26/1997 | EP0758893A1 Potentiated antibiotic composition |
| 02/26/1997 | EP0758892A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
| 02/26/1997 | EP0758891A1 HALOMETHYL AMIDES AS IL-1$g(b) PROTEASE INHIBITORS |
| 02/26/1997 | EP0758890A1 Use of no scavengers, inhibitors or antagonists in the treatment of migraine |
| 02/26/1997 | EP0758889A1 Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients |
| 02/26/1997 | EP0758888A1 Matrix system for the transdermal delivery of ibuprofen, and method for preparing same |
| 02/26/1997 | EP0758887A1 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical |
| 02/26/1997 | EP0758886A1 Use of perfluorocarbons for assisting normal breathing in mammals having lung disorders |
| 02/26/1997 | EP0758882A1 Methods of lightening hyperpigmented regions in mammalian skin |
| 02/26/1997 | EP0758879A1 Improved anti-dandruff shampoo |
| 02/26/1997 | EP0758843A1 Modified amino acids for drug delivery |
| 02/26/1997 | EP0732917A4 Nutritional supplement for optimizing cellular health |
| 02/26/1997 | EP0707581B1 Indoline derivatives as 5ht2c antagonists |
| 02/26/1997 | EP0705266B1 Process for producing imidazole derivative |
| 02/26/1997 | EP0690852B1 Method for purifying taxoids |
| 02/26/1997 | EP0673377B1 New triazoloquinazolines, their production and their use |
| 02/26/1997 | EP0625905A4 Composition containing body activated fragrance for contacting the skin and method of use. |
| 02/26/1997 | EP0593418B1 Alkali and alkaline earth salts of oxypurinol in amorphous or crystalline form as agents for treating hyperuricemia and gout |
| 02/26/1997 | EP0587819B1 Medetomidine preparations for transdermal administration |
| 02/26/1997 | EP0533781B1 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| 02/26/1997 | CN1143966A L-nucleosides for treatment of hepatitis B-virus and epstein-bar virus |
| 02/26/1997 | CN1143965A Carbocyclic compound |
| 02/26/1997 | CN1143964A Pyrrolopyridazine derivative |
| 02/26/1997 | CN1143963A Tetracyclic derivatives, process of preparation and use |
| 02/26/1997 | CN1143962A Triazole compound and processes for preparation thereof |
| 02/26/1997 | CN1143961A Oxazolidinone derivatives and pharmaceutical compositions containing them |
| 02/26/1997 | CN1143960A Heterocyclic compound for treatment |
| 02/26/1997 | CN1143959A Nicotinic acid derivatives and herbicide |
| 02/26/1997 | CN1143956A 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles, process for preparing same and their use as medicaments |
| 02/26/1997 | CN1143954A Anilide derivatives as fungicides |
| 02/26/1997 | CN1143953A Certain fused pyrrolecarboxanilides; new class of gaba brain receptor ligands |
| 02/26/1997 | CN1143950A Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure |
| 02/26/1997 | CN1143910A Chemical castration |
| 02/26/1997 | CN1143909A Antitussive composition containing antitussive and benzydamine |
| 02/26/1997 | CN1143908A Treatment of diabetic nephropathy with valsartan |
| 02/26/1997 | CN1143907A Pharmaceutical compositions |
| 02/26/1997 | CN1143647A Dipeptides which promote release of growth hormone |
| 02/26/1997 | CN1143644A N-|(1,4-diazadicyclo |2,2,2¨ oct -2-yl methyl¨ benzoic amide derivatives, its preparing process and medicinal use |
| 02/26/1997 | CN1143643A Paroxetine hydrochloride anhydrate substantially free of bound propan-2-ol |
| 02/26/1997 | CN1143642A New indole, indazole and benzisoxazole compounds, their process of preparation and pharmaceutical compositions which contain them |
| 02/26/1997 | CN1143639A Oxime derivatives, their preparation and their therapeutic use |
| 02/26/1997 | CN1143632A Fluorine-containing benzoylguanidines |
| 02/26/1997 | CN1143628A N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
| 02/26/1997 | CN1143507A Specific remedy for curing dysentery and diarrhea of domestic animals and poultry |
| 02/26/1997 | CN1143506A Anticholera Chinese medicine and medicine compound preparation for poultry |
| 02/26/1997 | CN1143500A Use of 1 alpha, 24-dihydroxy vitamin D2 |
| 02/26/1997 | CN1143499A Medicine for curing hyperplasia of mammary glands |